Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam versus valproate or carbamazepine monotherapy in newly diagnosed epilepsy
2004-001339-41Phase 3Completed
- Sponsor
- UCB
- Start
- Nov 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in epilepsy comparing Levetiracetam monotherapy, Sodium valproate monotherapy and Carbamazepine monotherapy (3 arms). Primary endpoint: Time to withdrawal from study medication. Started Nov 2004; status: completed.
02
Drugs
levetiracetamvalproic acidcarbamazepine
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2004-001339-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001339-41.